Alzheimer's Drug Race: Roche Ramps Up Drug Trial As Rivals Stumble
Results from the study in early, or prodromal, Alzheimer's patients who do not yet have dementia are expected in 2015. The decision to increase the number of patients to 770 from 360 has made it a pivotal, or final-stage Phase III, trial. While the …
See all stories on this topic ยป